食欲相关因子在精神分裂症睡眠障碍中的研究进展(4)
[18]an der Heiden W,Konnecke R,Maurer K,et al.Depression in the longterm course of schizophrenia[J].Eur Arch Psychiatry Clin Neurosci,2005,255(3):174184.
[19]Lutter M,Sakata I,OsborneLawrence S,et al.The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress[J].Nat Neurosci,2008,11(7):752753.
[20]Tolle V,Bassant MH,Zizzari P,et al.Ultradian rhythmicity of ghrelin secretion in relation with GH,feeding behavior,and sleepwake patterns in rats[J].Endocrinology,2002,143(4):13531361.
, 百拇医药
[21]Heilig M.The NPY system in stress,anxiety and depression[J].Neuropeptides,2004,38(4):213224.
[22]Karl T,Herzog H.Behavioral profiling of NPY in aggression and neuropsychiatric diseases[J].Peptides,2007,28(2):326333.
[23]Barnea A,Roberts J.Induction of functional and morphological expression of neuropeptide Y (NPY) in cortical cultures by brainderived neurotrophic factor (BDNF):evidence for a requirement for extracellularregulated kinase (ERK)dependent and ERKindependent mechanisms[J].Brain Res,2001,919(1):5769.
, 百拇医药
[24]Itokawa M,Arai M,Kato S,et al.Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans[J].Neurosci Lett,2003,347(3):202204.
[25]He C,Yang Y,Zhang M,et al.Regulation of sleep by neuropeptide Ylike system in Drosophila melanogaster[J].PLoS One,2013,8(9):74237.
[26]Steiger A.Neurochemical regulation of sleep[J].J Psychiatr Res,2007,41(7):537552.
, 百拇医药
[27]de Lecea L,Huerta R.Hypocretin (orexin) regulation of sleeptowake transitions[J].Front Pharmacol,2014,5:16.
[28]Antonijevic IA,Murck H,Bohlhalter S,et al.Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men[J].Neuropharmacology,2000,39(8):14741481.
[29]Dyzma M,Boudjeltia KZ,Faraut B,et al.Neuropeptide Y and sleep[J].Sleep Med Rev,2010,14(3):161165.
[30]Fadel JR,Jolivalt CG,Reagan LP.Food for thought:the role of appetitive peptides in agerelated cognitive decline[J].Ageing Res Rev,2013,12(3):764776.
, 百拇医药
[31]Yoon JH,Minzenberg MJ,Raouf S,et al.Impaired prefrontalbasal ganglia functional connectivity and substantia nigra hyperactivity in schizophrenia[J].Biol Psychiatry,2013,74(2):122129.
[32]Dalal MA,Schuld A,Pollmacher T.Lower CSF orexin A (hypocretin1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects[J].Mol Psychiatry,2003,8(10):836837.
[33]Scammell TE,Arrigoni E,Lipton JO.Neural Circuitry of Wakefulness and Sleep[J].Neuron,2017,93(4):747765., 百拇医药(武琪 李慧 王帆)
[19]Lutter M,Sakata I,OsborneLawrence S,et al.The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress[J].Nat Neurosci,2008,11(7):752753.
[20]Tolle V,Bassant MH,Zizzari P,et al.Ultradian rhythmicity of ghrelin secretion in relation with GH,feeding behavior,and sleepwake patterns in rats[J].Endocrinology,2002,143(4):13531361.
, 百拇医药
[21]Heilig M.The NPY system in stress,anxiety and depression[J].Neuropeptides,2004,38(4):213224.
[22]Karl T,Herzog H.Behavioral profiling of NPY in aggression and neuropsychiatric diseases[J].Peptides,2007,28(2):326333.
[23]Barnea A,Roberts J.Induction of functional and morphological expression of neuropeptide Y (NPY) in cortical cultures by brainderived neurotrophic factor (BDNF):evidence for a requirement for extracellularregulated kinase (ERK)dependent and ERKindependent mechanisms[J].Brain Res,2001,919(1):5769.
, 百拇医药
[24]Itokawa M,Arai M,Kato S,et al.Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans[J].Neurosci Lett,2003,347(3):202204.
[25]He C,Yang Y,Zhang M,et al.Regulation of sleep by neuropeptide Ylike system in Drosophila melanogaster[J].PLoS One,2013,8(9):74237.
[26]Steiger A.Neurochemical regulation of sleep[J].J Psychiatr Res,2007,41(7):537552.
, 百拇医药
[27]de Lecea L,Huerta R.Hypocretin (orexin) regulation of sleeptowake transitions[J].Front Pharmacol,2014,5:16.
[28]Antonijevic IA,Murck H,Bohlhalter S,et al.Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men[J].Neuropharmacology,2000,39(8):14741481.
[29]Dyzma M,Boudjeltia KZ,Faraut B,et al.Neuropeptide Y and sleep[J].Sleep Med Rev,2010,14(3):161165.
[30]Fadel JR,Jolivalt CG,Reagan LP.Food for thought:the role of appetitive peptides in agerelated cognitive decline[J].Ageing Res Rev,2013,12(3):764776.
, 百拇医药
[31]Yoon JH,Minzenberg MJ,Raouf S,et al.Impaired prefrontalbasal ganglia functional connectivity and substantia nigra hyperactivity in schizophrenia[J].Biol Psychiatry,2013,74(2):122129.
[32]Dalal MA,Schuld A,Pollmacher T.Lower CSF orexin A (hypocretin1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects[J].Mol Psychiatry,2003,8(10):836837.
[33]Scammell TE,Arrigoni E,Lipton JO.Neural Circuitry of Wakefulness and Sleep[J].Neuron,2017,93(4):747765., 百拇医药(武琪 李慧 王帆)